The Food and Drug Administration authorized an antiviral drug that has shown to be highly effective at preventing hospitalizations due to COVID-19, making it a powerful tool that could bolster the shaky medical system facing an omicron wave.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research.

Recommended Stories

Pfizer reports vaccine is highly effective at preventing infection from South Africa variant

Pfizer-BioNTech says COVID-19 vaccine 80% effective in children under 5

FDA limits monoclonal antibody treatments shown to be ineffective against omicron